Health

Stay informed on groundbreaking medical research and UC Health initiatives, exploring topics in healthcare and wellness.

Featured News

1

What would expanded access to GLP-1s mean for the obesity rate?

December 4, 2025

The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.

2

Glomerular disease treatment guidelines updated

December 1, 2025

Given the rapidly growing evidence base in glomerular disease, the Kidney Disease Improving Global Outcomes group, known as KDIGO, recently published an updated clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV). University of Cincinnati nephrologists recently shared what's new and what's next with MedCentral.

Latest News

1

What would expanded access to GLP-1s mean for the obesity rate?

December 4, 2025

The World Health Organization recently issued its first guidance on GLP-1 medications for adults with obesity — recommending long-term, continuous use when clinically appropriate. Malti Vij, MD, University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine, appeared on Cincinnati Edition on 91.7 WVXU News to discuss GLP-1s and what expanded insurance coverage of the medications might mean for Americans.

2

Glomerular disease treatment guidelines updated

December 1, 2025

Given the rapidly growing evidence base in glomerular disease, the Kidney Disease Improving Global Outcomes group, known as KDIGO, recently published an updated clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV). University of Cincinnati nephrologists recently shared what's new and what's next with MedCentral.